Literature DB >> 6417292

Possible teratogenic effect of valproate during pregnancy.

S Koch, E Jäger-Roman, D Rating, H Helge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6417292     DOI： 10.1016/s0022-3476(83)80750-1

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  4 in total

1.  Pharmacokinetic aspects of drug effects in vitro: effects of serum protein binding on concentration and teratogenicity of valproic acid and 2-en-valproic acid in whole embryos in culture.

Authors:  C Lewandowski; S Klug; H Nau; D Neubert
Journal:  Arch Toxicol       Date:  1986-04       Impact factor: 5.153

2.  Malformations, withdrawal manifestations, and hypoglycaemia after exposure to valproate in utero.

Authors:  E Thisted; F Ebbesen
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

3.  The enantiomers of the valproic acid analogue 2-n-propyl-4-pentynoic acid (4-yn-VPA): asymmetric synthesis and highly stereoselective teratogenicity in mice.

Authors:  R S Hauck; H Nau
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

4.  Species differences in pharmacokinetics and drug teratogenesis.

Authors:  H Nau
Journal:  Environ Health Perspect       Date:  1986-12       Impact factor: 9.031
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.